These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9841787)

  • 1. Structural and functional meta-analytic evidence for fronto-subcortical system deficit in progressive supranuclear palsy.
    Zakzanis KK; Leach L; Freedman M
    Brain Cogn; 1998 Dec; 38(3):283-96. PubMed ID: 9841787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral perfusion in progressive supranuclear palsy.
    Johnson KA; Sperling RA; Holman BL; Nagel JS; Growdon JH
    J Nucl Med; 1992 May; 33(5):704-9. PubMed ID: 1569479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological features of progressive supranuclear palsy.
    Grafman J; Litvan I; Stark M
    Brain Cogn; 1995 Aug; 28(3):311-20. PubMed ID: 8546857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ; Konkel A; Dąbrowska M; Sławek J
    Neurol Neurochir Pol; 2015; 49(1):36-40. PubMed ID: 25666771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.
    Borroni B; Alberici A; Agosti C; Cosseddu M; Padovani A
    Int Psychogeriatr; 2009 Jun; 21(3):463-8. PubMed ID: 19323870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia.
    Chiu WZ; Papma JM; de Koning I; Donker Kaat L; Seelaar H; Reijs AE; Valkema R; Hasan D; Boon AJ; van Swieten JC
    J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):910-5. PubMed ID: 22733085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of atypical progressive supranuclear palsy.
    Spaccavento S; Del Prete M; Craca A; Loverre A
    Clin Interv Aging; 2014; 9():31-9. PubMed ID: 24368882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive deficits in progressive supranuclear palsy].
    Kułakowska A; Pyd E; Halicka D; Pogorzelski R; Drozdowski W
    Neurol Neurochir Pol; 2003; 37 Suppl 5():203-10. PubMed ID: 15098348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.
    Foster NL; Gilman S; Berent S; Sima AA; D'Amato C; Koeppe RA; Hicks SP
    J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):707-13. PubMed ID: 1527543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progressive supranuclear palsy: neurological, neuropathological and neuropsychological aspects].
    Gómez-Haro C; Espert-Tortajada R; Gadea-Doménech M; Navarro-Humanes JF
    Rev Neurol; 1999 Nov 16-30; 29(10):936-56. PubMed ID: 10637844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy: analysis of six cases.
    Marra M; Toni V; Trianni G; Coppola G
    Neurol Sci; 2003 Oct; 24(3):186-7. PubMed ID: 14598079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations.
    Blin J; Baron JC; Dubois B; Pillon B; Cambon H; Cambier J; Agid Y
    Arch Neurol; 1990 Jul; 47(7):747-52. PubMed ID: 2357154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Duff K; McDermott D; Luong D; Randolph C; Boxer AL
    J Clin Exp Neuropsychol; 2019 Jul; 41(5):469-475. PubMed ID: 30712468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb apraxia and cognitive impairment in progressive supranuclear palsy.
    Soliveri P; Piacentini S; Girotti F
    Neurocase; 2005 Aug; 11(4):263-7. PubMed ID: 16093226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
    Foster NL; Gilman S; Berent S; Morin EM; Brown MB; Koeppe RA
    Ann Neurol; 1988 Sep; 24(3):399-406. PubMed ID: 3265862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in patients with progressive supranuclear palsy.
    Schrag A; Selai C; Davis J; Lees AJ; Jahanshahi M; Quinn N
    Mov Disord; 2003 Dec; 18(12):1464-9. PubMed ID: 14673883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlations of microstructural changes in progressive supranuclear palsy.
    Tessitore A; Giordano A; Caiazzo G; Corbo D; De Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Neurobiol Aging; 2014 Oct; 35(10):2404-10. PubMed ID: 24786632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal presentation in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Kamphorst W; Ravid R; Duivenvoorden HJ; van Swieten JC
    Neurology; 2007 Aug; 69(8):723-9. PubMed ID: 17709703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.